Geoffrey Beran Rose
2023
In 2023, Geoffrey Beran Rose earned a total compensation of $2M as Chief Commercial Officer at Pulmonx Corp, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,627 |
|---|---|
| Option Awards | $419,751 |
| Salary | $430,000 |
| Stock Awards | $905,772 |
| Other | $666 |
| Total | $1,957,816 |
Rose received $905.8K in stock awards, accounting for 46% of the total pay in 2023.
Rose also received $201.6K in non-equity incentive plan, $419.8K in option awards, $430K in salary and $666 in other compensation.
Rankings
In 2023, Geoffrey Beran Rose's compensation ranked 524th out of 2,647 executives tracked by ExecPay. In other words, Rose earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 524 out of 2,647 | 80th |
Division Manufacturing | 302 out of 1,447 | 79th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 31 out of 220 | 86th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 24 out of 157 | 85th |
Industry Surgical and Medical Instruments and Apparatus | 23 out of 120 | 81st |
Source: SEC filing on April 5, 2024.
Rose's colleagues
We found three more compensation records of executives who worked with Geoffrey Beran Rose at Pulmonx Corp in 2023.